EcoDrugPlus

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSPNAG00000027826
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSPNAG00000012748
Gene Symbol: IGF1R
3 Cross references
205 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSPNAG00000010410
Gene Symbol: INSR
3 Cross references
212 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSPNAG00000010896
Gene Symbol: LOC108415638
3 Cross references
213 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSPNAG00000014746
Gene Symbol: LOC108428482
3 Cross references
203 Possible Orthologues:

Integrin Alpha-Iib-Like

Ensembl ID : ENSPNAG00000002886
Gene Symbol: LOC108413642
3 Cross references
190 Possible Orthologues:

Integrin Beta-1-B-Like

Ensembl ID : ENSPNAG00000016842
Gene Symbol: LOC108442929
3 Cross references
221 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSPNAG00000016909
Gene Symbol: LOC108442945
3 Cross references
218 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSPNAG00000010208
Gene Symbol: LOC108430317
3 Cross references
194 Possible Orthologues:

Integrin Beta-7-Like

Ensembl ID : ENSPNAG00000005490
Gene Symbol: LOC108433259
2 Cross references
133 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSPNAG00000024765
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPNAG00000021947
Gene Symbol: ITGA5
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).